San Mateo, CA, United States of America

John Thomas Feutrill

This inventor holds 1 USPTO granted patent. Top assignee: Glaxosmithkline LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Thomas Feutrill. Retrieved from https://idiyas.com/inventor/john-thomas-feutrill-6xf17tmx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John Thomas Feutrill: Innovator in Phenyl Amino Pyrimidine Compounds

Introduction

John Thomas Feutrill is a notable inventor based in San Mateo, CA. He has made significant contributions to the field of chemistry, particularly with his work on phenyl amino pyrimidine compounds. His innovative approach has led to the development of a patent that showcases his expertise and creativity.

Latest Patents

Feutrill holds a patent for "Phenyl Amino Pyrimidine Compounds and Uses Thereof." This patent highlights his ability to create compounds that may have various applications in the pharmaceutical industry. His work is a testament to the importance of innovation in developing new solutions for health-related challenges.

Career Highlights

Feutrill is currently employed at GlaxoSmithKline LLC, a leading global healthcare company. His role at the company allows him to collaborate with other talented professionals in the field. With a total of 1 patent to his name, he has established himself as a valuable contributor to the scientific community.

Collaborations

Throughout his career, Feutrill has worked alongside notable colleagues such as Christopher John Burns and Andrew Craig Donohue. These collaborations have likely enriched his work and contributed to the success of his projects.

Conclusion

John Thomas Feutrill is an accomplished inventor whose work on phenyl amino pyrimidine compounds exemplifies the spirit of innovation. His contributions to GlaxoSmithKline LLC and the broader scientific community highlight the importance of collaboration and creativity in advancing technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…